Statement Of Financial Position [Abstract]

Ascelia Pharma - Filing #689421

Concept	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	163,000 SEK	—	—	—	—	—	—	—	—	238,000 SEK	—	—	—	—	—	—	—	—	—	—	—
Right-of-use assets	462,000 SEK	—	—	—	—	—	—	—	—	1 581 SEK	—	—	—	—	—	—	—	—	—	—	—
Intangible assets other than goodwill	57 074 SEK	—	—	—	—	—	—	—	—	57 063 SEK	—	—	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	149 555 SEK	—	—	—	—	—	—	—	—	261 599 SEK	—	—	—	—	—	—	—	—	—	—	184 686 SEK
Assets	218 569 SEK	—	—	—	—	—	—	—	—	333 493 SEK	—	—	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	34 871 SEK	—	—	—	—	—	—	—	—	34 576 SEK	—	—	—	—	—	—	—	—	—	—	—
Retained earnings	533 478 SEK	—	—	—	—	—	—	—	—	405 827 SEK	—	—	—	—	—	—	—	—	—	—	—
Equity attributable to owners of parent	180 859 SEK	—	—	—	—	—	—	—	—	307 834 SEK	—	—	—	—	—	—	—	—	—	—	—
Equity	180 859 SEK	– SEK	533 732 SEK	34 871 SEK	972,000 SEK	180 859 SEK	678 747 SEK	405 827 SEK	678 831 SEK	307 834 SEK	307 834 SEK	– SEK	254,000 SEK	34 576 SEK	286 491 SEK	– SEK	493 731 SEK	236 056 SEK	28 697 SEK	119,000 SEK	236 056 SEK
Liabilities [abstract]
Liabilities	37 711 SEK	—	—	—	—	—	—	—	—	25 659 SEK	—	—	—	—	—	—	—	—	—	—	—
Equity and liabilities	218 569 SEK	—	—	—	—	—	—	—	—	333 493 SEK	—	—	—	—	—	—	—	—	—	—	—